When diagnosed with mesothelioma, treatment of the cancer will be the most important next step for any patient. For nearly a decade, most treatments consisted of some form of surgery. Normally, a complete resection is necessary for this to be the most effective. Surgery alone is almost never recommended. Instead, most medical experts have a preferred approach of chemotherapy, radiation or both forms of treatment in addition to surgery. A combination of methods of treatment such as this are referred to as multimodality treatment. It has demonstrated the best results when compared to any single approach.
Chemotherapy alone was the earliest recommended mesothelioma treatment for most patients but is now rarely prescribed as a single agent. Protocols for this type of agent typically call for two or more complementary agents which are distinctly different targets for each therapy. Over decades of statistical data gathering doctors have proven that single protocol treatments have far less impact than multimodality treatment recommendations. Thus, single agent protocols are normally only recommended when the patients’ health is too delicate to warrant more than one approach.
When given a mesothelioma diagnosis, most patients want to help you make sense of what is their mesothelioma prognosis and what mesothelioma treatment option will be best to increase their life expectancy. Patients who are deemed healthy enough to undergo a multimodality treatment for mesothelioma should only do so at a medical facility and with medical professionals that are highly experienced in treating mesothelioma patients. Surgeries such as extrapleuralpneumonectomy carry significantly high risk levels for mortality when performed by surgeons and post-surgical teams having limited experience. Circumventing issues related with these surgeries is the key to surviving them.
Most medical professionals agree that surgery provides the best chance for successful recoveries by patients. They will also agree that they can present some serious and even life-threatening side-effects. These life-threatening issues can include digestive problems, nerve damage, pneumonitis, lung infection, empyema, bronchoplenral fistula, heart arrhythmia, chest pain, abdominal pain, constipation, hemoptysis, pulmonary embolism, pneumothorax, or hemorrhage. The surgery itself could present malignant seeding at the site of the incisions.
Mesothelioma chemotherapy could leadto another, completely different set of morbidity issues includinghair loss, loss of appetite, neuropathytinitus, weight loss, nausea and low blood counts of red and white blood cells. Despite these risks, mesothelioma treatment has progressed significantly in efforts to fight the disease. Selecting the right medical team of experts is definitely the key to prolonged mesothelioma life expectancy as this is significant in skillful intervention of the progression of the disease.